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We report an efficient, atom economical general acid-base 
catalyzed one-step multi-gram synthesis of azepinomycin 
from commercially available compounds in water. We 
propose that the described pH-dependent Amadori 
rearrangement, which couples an amino-imidazole and 
simple sugar, is of importance as a potential step toward 
predisposed purine nucleotide synthesis at the origins of 
life. 
Nucleotides and nucleic acids are compounds of privileged biological 
importance and, consequently, nucleotide and nucleobase analogues have 
found great importance in pharmaceutical chemistry.1  
 
Scheme 1: Protecting-group-free synthesis of azepinomycin 2 (R=H) and 
azepinomycin riboside 5 (R=β-D-ribofuranosyl) in water. N-Acyl-hemiaminal 
N—H shown bold. 
Here we demonstrate an amino-imidazole tethering strategy that uses an 
Amadori rearrangement, which couples glycolaldehyde (1) to 5-amino-
imidazole-4-carboxamide (AICA), and consequently the synthesis of 
azepinomycin (2),2 a guanine deaminase inhibitor isolated from the culture 
filtrate of Streptomyces sp (Scheme 1) containing an N-acyl hemiaminal 
synthesized by direct conjugation of an aldehyde and amide in neutral 
water.2,3 We propose that this could have been a key step in the regiospecific 
coupling of purine precursors to sugars at the onset of biology, before the 
advent of enzymatically-controlled biosynthesis. 
 The synthesis of 5-amino-imdiazole-4-carbonitrile (AICN) and AICA from 
hydrogen cyanide tetramer (DAMN) was demonstrated more than 60 years 
ago by a remarkable photochemical rearrangement (Scheme 2).4 Further 
chemical elaboration of AICN and AICA to the canonical purine 
nucleobases has been reported, however poor selectivity and very low yields 
for purine nucleobases ribosylation with free sugars5 has cast doubt upon the 
plausibility of purine nucleoside synthesis by direct glycosylation of 
nucleobases.6,7  
 
Scheme 2: Oligomerisation of hydrogen cyanide to diaminomaleonitrile 
(DAMN) and subsequent photochemical isomerisation and hydrolysis to 5-
amino-imidazole-4-carbonitrile (AICN) and 5-amino-imidazole-4-
carboxamide (AICA)  
 
The great difficulties incurred by ribosylation of purine nucleobases and 
observed intermediacy of 5-amino-imidazole-4-carboxamide riboside 
(AICAR) in de novo purine synthesis have led to our interest in the reactivity 
of AICA to develop new strategies to tether sugars and purine precursors.7,8,9 
Specifically, we have previously proposed that the 1,5-disposition of the 
N
N N
H
N
O
OH
R
N
N NH2
NH2
O
R
O
OH
NaH2PO4
H2O
N
N N
NH2
O
N
N NH
NH2
O
OOH
AICA R=H 1
3 4
AICAR R=ribosyl
2 R=H
H
R R
5 R=ribosyl
pH 6.5
pH 4.01 H2N
CNH2N
CN N
N
H NH2
CN N
N
H NH2
4HCN
O
NH2
DAMN AICN AICA
hν H2O
COMMUNICATION	   Journal	  Name	  
2 	  |	  J.	  Name.,	  2012,	  00,	  1-­‐3	   This	  journal	  is	  ©	  The	  Royal	  Society	  of	  Chemistry	  2012	  
imidazole and amine moieties of AICA provide the inherent regioselectivity 
required to deliver the correct N7-ribosylation of purine nucleotides in the 
absence of sophisticated enzymatic control. We have previously 
demonstrated pH-controlled multicomponent coupling of AICA, aldehydes 
and 2-amino-azoles that leads to regiospecific coupling of AICA (by the 
correct N1-nitrogen atom) to masked tetrose and pentose sugars in excellent 
yields.8 Here we report a complementary tethering strategy for AICA and 1 
by Amadori rearrangement in neutral aqueous phosphate buffer. The nature 
of the reaction conditions, the compounds (AICA and 1) and the remarkable 
efficiency and selectivity signify the potential importance of the reaction in 
elucidating the chemical origins of life. 
Four syntheses of azepinomycin (2) have previously been reported. Isshiki et 
al. reported both seven- and six-step sequences to 2 in 5% or 6% overall 
yield, respectively.2 Fuji et al. reported an eleven-step sequence to yield 2 in 
5% overall yield.10 Finally, in 2012, Hosmane and co-workers reported a 
seven-step synthesis providing access to 2 in 16% yield from AICAR.11 
During the course of studying of the chemical origins of ribonucleotides we 
noted that 2 is, constitutionally, a conjugate of glycolaldehyde (1) and AICA. 
We had previously observed both highly efficient trapping of AICA as Schiff 
bases 3 in water8,9 and the remarkable efficacy of phosphate, acting as a 
general acid-base catalyst, mediating neutral-pH proton transfer.12 Our 
analysis of 2 suggested that, under conditions when rapid tautomerisation of 
imine 3 and aldehyde 4 was observed, 2 would be a privileged chemical 
structure, accessible in one protecting-group-free step from commercially 
available reagents by sequential imine formation, Amadori rearrangement 
and amine-tethered dehydration. 
Pleasingly, incubation of AICA (0.08M) and 1 (0.15M) in aqueous 1M-
phosphate buffer at 60ºC for 24 h gave a facile and near quantitative 
synthesis of 2 in 83% yield. Purification of 2 (pKa 4.2; see supplementary 
information) can be conveniently achieved by solid-phase extraction with 
ion-exchange resin (proton-form Dowex® 50W) and liberation of 2 from 
Dowex® is then achieved at pH≥7 to give a 1.16 g (80%) isolated yield of 2. 
Heterocycle 2 can then be further purified by (unoptimized) recrystallisation 
to afford crystalline 2 in 60% yield after one protecting-group-free step 
without any requirement for chromatography.† 
1H-NMR studies indicate that the N-acyl hemiaminal N—H bond of 2 
(Scheme 1; N—H shown bold) exchanges slowly and is observed as a 
doublet (1H NMR (H2O:D2O, 10:1) δH 8.06 ppm, J = 5.6 Hz) in 1H-NMR 
spectra acquired of H2O solutions of 2 (1H NMR spectra of 2 in DMSO, 
H2O:D2O (10:1), D2O are provided in Supplementary Information). The slow 
exchange of N-acyl hemiaminals has been observed previously and attributed 
to intramolecular hydrogen bonding,13 however the bicyclic architecture of 2 
prohibits intramolecular hydrogen bonding suggesting inductive or 
stereoelectronic inhibition of proton-exchange in 2. Evidence of an anomeric 
effect is provided by the axial position of hemiaminal moiety in crystal 
structure (Figure 1).† 
 
Figure 1: Single crystal X-ray structure of azepinomycin (2) crystallised 
from aqueous ethanol (H2O:EtOH 9:1). 
 
En route to 2, Hosmane et al. isolated the two diastereomeric ribosides 5 
in a combined 27% yield.11 Though it was predicted that ribosylation of 2 
may improve bioactivity, it was observed to diminish guanine deaminase 
inhibitor activity. Though our primary goal was to establish the chemical 
reactivity of AICA and 1, we thought it imperative to also investigate the 
reactivity of AICAR. Firstly, to demonstrate the stability of the 
glycosidic bond of AICAR under the conditions that facilitate Amadori 
rearrangement, and secondly, to investigate the potential derivatisation of 
AICAR. AICAR Amadori rearrangement provides a rapid, protecting-
group-free method to access 5, however could be highly detrimental to 
further development of purine nucleotide synthesis under phosphate 
buffer reaction conditions. 
Interestingly, we observed no reaction between AICAR and 1 in pH 6-
phosphate buffer. Indeed, 1 was completely consumed in a slow homo-
aldol/Lobry de Bruyn-Alberda van Ekenstein rearrangement over the 
course of 4 - 5 days at 60ºC to give erythulose, whereas AICAR (within 
the limits of 1H-NMR detection) remain unaltered by phosphate buffer or 
glycolaldehyde-modification at pH 6.5.‡ We hypothesise that the change 
in pKa14 of AICAR relative to the aglycone, AICA, prohibited iminium 
formation and, therefore, protected AICAR from derivatisation by 
inhibition of the Amadori rearrangement. Interestingly, with respect to 
further elaboration of purine ribonucleotides, the switch in reactivity 
observed protects AICAR from subsequent (undesirable) derivatisation 
by the aldehydic precursors of nucleotides in phosphate buffer.  
In support of our hypothesis that the observed pKa shift protects AICAR 
from derivatisation at neutral pH, we found that Amadori rearrangement 
of AICA and 1 was not observed at pH > 8. Consequently, we proposed 
that Amadori rearrangement of AICAR would be observed at low pH. 
We were pleased to observe that at pH 3 – 4 in phosphate or acetate 
buffer, conversion of AICAR to 5 was indeed switched on, such that in 
aqueous solution at pH 4 preparation of 5 could be achieved in 50 – 65% 
yield over 3 – 4 days at 60ºC directly from AICAR. The equilibrating 
diastereomers of 5 (H2O, 1.2:1),11 were then isolated by solid-phase 
extraction with ion-exchange resin (proton-form Dowex® 50W) and 
separated for individual analysis by preparative RP-HPLC.  
Conclusions 
We have demonstrated a high-yielding, atom-economical, 
chromatography-free, and protecting-group-free strategy for the 
synthesis of azepinomycin (2). Additionally, we described the pH 
dependence of aminoimidazole—glycolaldehyde Amadori 
rearrangement leading to deferential synthesis of azepinomycin 
ribosides (5) and azepinomycin (2). 
Importantly, with respect to the origins of life, these results demonstrate 
highly effective sugar-C2'—(5-amino)-imidazole tethering of 
carbohydrates and 5-aminoimidazoles, which are important purine 
nucleobase precursors. An investigation of the predisposed15 Amadori 
rearrangement towards the origin of purine ribonucleotides in biology is 
underway in our laboratory. 
Experimental 
Glycolaldehyde dimer was purchased from Sigma-Aldrich, 5-
aminoimidazole-4-carboxamide (AICA) was purchased from Acros 
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Organics, and AICA-riboside (AICAR) was purchased from 
Fluorochem. Solvents were obtained from Fischer Scientific. All 
reagents and solvents were used without further purification. Dowex 
50WX8 200-400 mesh ion exchange resin was purchased from Acros 
Organics and was washed with methanol and sodium hydroxide 
solution before being regenerated with hydrochloric acid solution. 
NMR spectra were recorded on either a Bruker 600 MHz or Oxford 400 
MHz spectrometer in D2O, DMSO-d6 or a mixture of H2O and D2O and 
chemical shifts are reported in ppm, referenced to the residual solvent 
signals. Mass spectrometry was carried out on a Waters LCT Premier 
XE spectrometer. HPLC was carried out on an Agilent 1260 system 
with a Polaris 5 C18-A analytical (150 x 4.6 mm) or semi-preperative 
(150 x 10 mm) column at 30°C with injection volumes of 5 or 100 µL 
(10 mg/mL) and flow rates of 1 or 5 mL/min respectively. 
 
Azepinomycin 2 
A solution of 5-aminoimidazole-4-carboxamide hydrochloride AICA 
(1.38 g, 8.5 mmol) and glycolaldehyde dimer (0.90 g, 15 mmol) in 
aqueous sodium phosphate (1M, 100 mL, pH 6) was prepared and 
incubated at 60°C for 24 h. The solution was diluted to 500 mL with 
water and run through a column of Dowex® 50WX8 ion exchange 
resin (H+ form, ca. 300 mL, 1.7 meq/mL) and the resin was then 
washed with 1 bed volume of water. The resin was suspended in water 
(300 mL), the pH was raised to pH 7 with sodium hydroxide (4M) and 
the suspension was filtered. The resin was further washed with water 
and the combined filtrate and washings were lyophilised. The resulting 
solid was dried over P2O5 giving 2 (1.16 g, 80%) as a fine cream 
powder. A portion (1.0 g) of material was further purified by 
crystallisation from water:ethanol (1:1, 20 mL) at 0°C. The solids were 
collected by filtration and washed with ice-cold ethanol and then 
diethyl ether giving an off white solid (0.6 g, 60%). Analytical samples 
of x-ray quality crystals were obtained by vapour diffusion of ethanol 
into an aqueous solution of compound 2. Rf: 0.24 (CH2Cl2: 1% NH3 in 
MeOH, 5 : 3). M.p. 194-230°C (dec) [lit. 208-220°C (dec.)]10. IR (cm-1) 
3285 (NH); 3105 br (OH); 2279, 2823 (CH); 1592, 1546 (C=O, C=N). 
1H NMR (600 MHz, DMSO) δH 11.83 (1H, br s, N1-H); 7.75 (1H, d, J 
= 5.6 Hz, N9-H); 7.32 (1H, d, J = 1.1 Hz, C2-H); 6.28 (1H, dd, J = 5.6, 
2.2 Hz, N6-H); 5.39 (1H, d, J = 5.6 Hz, OH); 4.74 (1H, q, J = 5.6 Hz, 
C8-H); 3.36 (signal obscured by HDO peak, C7-Ha); 2.87 (1H, dd, J = 
13.2, 2.2 Hz, C7-Hb). 1H NMR (600 MHz, D2O:H2O 1:10) δH 8.05 
(0.5H, br d, 5.6 Hz, N9-H); 7.58 (1H, s, C2-H); 5.16 (1H, t, J = 5.6 Hz, 
C8-H); 3.69 (1H, dt, J = 13.8, 5.6 Hz, C7-Ha); 3.12 (1H, d, J = 13.8 Hz, 
C7-Hb). 1H NMR (600 MHz, D2O) δH 7.59 (1H, s, C2-H); 5.16 (1H, d, 
J = 5.6 Hz, C8-H); 3.70 (1H, dd, J = 13.8, 5.6 Hz, C7-Ha); 3.13 (1H, d, 
J = 13.8 Hz, C7-Hb). 13C NMR (150 MHz, DMSO) δC 161.3 (q, C10); 
150.8 (q, C5); 136.2 (CH, C2); 105.5 (q, C4); 72.6 (CH, C8); 48.5 
(CH2, C7). UV-vis: λmax (H2O, pH 8) 287 nm (ε 9100). m/z (EI+) 168 
(100%, [M+]); 169 (92%, [M+H+]); 95 (38%); 123 (29%); 68 (26%); 
122 (25%) 140 (25%) 151 (20%). HRMS C6H8N4O2 calcd. 168.06473, 
found 168.06512. 
 
N1-(β-D-ribofuranosyl)-(8R)-azepinomycin 5A and N1-(β-D-
ribofuranosyl)-(8S)-azepinomycin 5B 
 
A solution of AICAR (200 mg, 0.75 mmol) and glycolaldehyde dimer 
(450 mg, 7.5 mmol) in aqueous sodium phosphate (1M, 7.9 mL, pH 6) 
was prepared and incubated at 60°C for 96 h. The solution was diluted 
with water (16 mL) and passed through a column of Dowex® 50WX8 
ion exchange resin (H+ form, ca. 50 mL, 1.7 meq/mL), which was 
subsequently washed with water (100 mL). The resin was then removed 
from the column, suspended in water and the pH was adjusted to pH 7 
with sodium hydroxide (4M). The suspension was filtered and the resin 
washed with water (100 mL). The combined filtrate and washings were 
lyophilised returning crude 5 (180 mg) as a mixture of 
diastereoisomers. A small sample of this material was subjected to 
semi-preparative HPLC (isocratic water), returning each of the 
diastereomers (retention times 3.9 and 4.9 min, respectively) as fine 
white powders after lyophilisation.  
5A. 1H NMR (600 MHz, D2O) δH 7.59 (1H, s, C2-H); 5.70 (1H, d, J = 
6.0 Hz, C1′-H); 5.17 (1H, d, J = 5.4 Hz, C8-H); 4.64 (1H, t, J = 6.0 Hz, 
C2′-H); 4.37 (1H, dd, J = 6.0, 3.2 Hz, C3′-H); 4.22 (1H, q, J = 3.2Hz, 
C4′-H); 3.89 (1H, dd, J = 12.6, 3.2 Hz, C5′-Ha); 3.85 (1H, dd, J = 12.6, 
3.2 Hz, C5′-Hb); 3.76 (1H, dd, J = 14.0, 5.4 Hz, C7-Ha); 3.21 (1H, d, J 
= 14.0 Hz, C7-Hb). 13C NMR (150 MHz, D2O) δC 167.2 (C10); 144.1 
(C5); 133.4 (C2); 114.4 (C4); 88.8 (C1′); 85.9 (C4′); 73.0 (C2′); 72.8 
(C8); 70.9 (C3′); 61.5 (C5′); 47.7 (C7). m/z (ES+) 301 (100%, 
[M+H+]). HRMS C11H17N4O6 calcd. 301.1148, found 301.1150. 
5B. 1H NMR (600 MHz, D2O) δH 7.60 (1H, s, C2-H); 5.66 (1H, d, J = 
5.7 Hz, C1′-H); 5.18 (1H, d, J = 5.8 Hz, C8-H); 4.68 (1H, t, J = 5.7 Hz, 
C2′-H); 4.36 (1H, dd, J = 5.7, 3.4 Hz, C3′-H); 4.23 (1H, q, J = 3.4Hz, 
C4′-H); 3.85 (1H, dd, J = 12.8, 3.4 Hz, C5′-Ha); 3.80 (1H, dd, J = 12.8, 
3.4 Hz, C5′-Hb); 3.77 (1H, dd, J = 14.0, 5.8 Hz, C7-Ha); 3.22 (1H, d, J 
= 14.0 Hz, C7-Hb). 13C NMR (150 MHz, D2O) δC 167.1 (C10); 144.6 
(C5); 132.9 (C2); 114.0 (C4); 88.2 (C1′); 85.9 (C4′); 73.3 (C2′); 72.8 
(C8); 71.0 (C3′); 61.6 (C5′); 47.7 (C7). m/z (ES+) 301 (100%, 
[M+H+]). HRMS C11H17N4O6 calcd. 301.1148, found 301.1146. 
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